NEWS

MEDIA

MEPSGEN, developing new medicines using human organs-on-chips technology

MEPSGEN, developing new medicines using human organs-on-chips technology

2023-02-13

 YongTae Kim(CEO of MEPSGEN) is attending 'MPS and Beyond symposium'

YongTae Kim(CEO of MEPSGEN) is attending 'MPS and Beyond symposium'

2023-02-08

Online seminar : 'Microphysiological Barrier System for Drug Development'

Online seminar : 'Microphysiological Barrier System for Drug Development'

2023-02-06

2022 13th Korean Tissue Engineering and Regenerative Medicine Society.

2022 13th Korean Tissue Engineering and Regenerative Medicine Society.

2022-12-09

MEPSGEN is attending the 2022 Korean BioChip Society Fall Conference in Jeju, November 2-4.

MEPSGEN is attending the 2022 Korean BioChip Society Fall Conference in Jeju, November 2-4.

2022-11-02

[1st block of Bio] Sharing the interview of Robert Langer, MIT professor.

[1st block of Bio] Sharing the interview of Robert Langer, MIT professor.

2022-10-24

Organ-on-a-chip will surely play critical roles in predictive clinical trials, including faster time to drug discovery

Organ-on-a-chip will surely play critical roles in predictive clinical trials, including faster time to drug discovery

2022-10-20

MEPSGEN_2022 KAAT Conference: 3D MPS and Organoid meet together.

MEPSGEN_2022 KAAT Conference: 3D MPS and Organoid meet together.

2022-09-02

Hoon Suk Rho(CTO of MEPSGEN) presenting MEPSGEN at BIOPLUS INTERPHEX KOREA 2022, COEX.

Hoon Suk Rho(CTO of MEPSGEN) presenting MEPSGEN at BIOPLUS INTERPHEX KOREA 2022, COEX.

2022-08-02

MEPS-BBB was selected for Blood-brain barrier research model  at Goizueta Alzheimer’s Disease Research Center, Emory University.

MEPS-BBB was selected for Blood-brain barrier research model at Goizueta Alzheimer’s Disease Research Center, Emory University.

2022-07-15

MEPSGEN Adds $7.94 Million to Series B

MEPSGEN Adds $7.94 Million to Series B

2022-07-14

‘Organ-on-a-chip’, capable of replacing 500 million laboratory animals per year... venture investment, showed movements.

‘Organ-on-a-chip’, capable of replacing 500 million laboratory animals per year... venture investment, showed movements.

2022-07-13

MEPSGEN, “Spur the development of new drugs based on human organ on a chip”

MEPSGEN, “Spur the development of new drugs based on human organ on a chip”

2022-07-13

MEPSGEN-OSONG Medical Innovation Foundation, Discussed about mutual cooperation and confirmed foundation infrastructure.

MEPSGEN-OSONG Medical Innovation Foundation, Discussed about mutual cooperation and confirmed foundation infrastructure.

2022-07-06

MEPSGEN, Participating Asia's largest global startup fair "Nextrise, Seoul 2022"

MEPSGEN, Participating Asia's largest global startup fair "Nextrise, Seoul 2022"

2022-06-16

[KOREA PHARM & BIO 2022] Mepsgen introduces its booth at KOREA PHARM & BIO 2022

[KOREA PHARM & BIO 2022] Mepsgen introduces its booth at KOREA PHARM & BIO 2022

2022-06-13

[YOUTUBE] MEPSGEN, presenting 3D Organ-on-a-chip at Bio Korea 2022. "Possible to overcome the limitations of the 2D platform"

[YOUTUBE] MEPSGEN, presenting 3D Organ-on-a-chip at Bio Korea 2022. "Possible to overcome the limitations of the 2D platform"

2022-06-03

MEPSGEN, presenting 3D Organ-on-a-chip at Bio Korea 2022. "Possible to overcome the limitations of the 2D platform"

MEPSGEN, presenting 3D Organ-on-a-chip at Bio Korea 2022. "Possible to overcome the limitations of the 2D platform"

2022-05-11

[BIO KOREA 2022] Mepsgen introduces its booth at BIO KOREA 2022

[BIO KOREA 2022] Mepsgen introduces its booth at BIO KOREA 2022

2022-05-11

MEPSGEN became a new member of Korea Bio Technology Industry Organization (KOREABIO)

MEPSGEN became a new member of Korea Bio Technology Industry Organization (KOREABIO)

2022-04-20

Sitemap닫기

ABOUT
OVERVIEW
VISION
HISTORY
ORGANIZATION
OVERSEAS
CI
CONTACT
TECHNOLOGY
HUMAN ORGAN-ON-A-CHIP
BIOMIMETIC NANOPARTICLE
NANOPARTICLE MANUFACTURING
PIPELINE
MEPS-X
MG-X
SERVICE
SERVICE
NEWS
NOTICE
MEDIA
ARTICLE
CAREERS
CULTURE
HIRING PROCESS
WE'RE HIRING!